US-based pharmaceutical company Catalent Pharma Solutions plans to raise $450m through the private placement of senior unsecured notes, due 2026.
The company plans to use the funds for the acquisition of Cook Pharmica.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Hong Kong-based pharmaceutical and health products manufacturer China Grand Pharmaceutical and Healthcare Holdings (formerly Maxx Bioscience Holdings) has announced the private placement of 47 million shares priced at HK$2.24 ($0.29) a share to raise HK$106.96m ($13.7m).
US-based biotechnology company Recursion Pharmaceuticals and Japanese firm Takeda Pharmaceutical have signed a research agreement to use the former’s AI-augmented phenotypic discovery platform to develop pre-clinical candidates for the latter.
Takeda will initially make an upfront payment of $90m followed by royalty payments from the sale of new drugs.
Ferring Pharmaceuticals has signed an agreement with Antares Pharma to acquire the worldwide rights to the latter’s ZomaJet needle-free auto injector device for $14.5m.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe acquisition will strengthen Ferring Pharma’s growth hormone product portfolio.
Both companies involved in the deal are based in the US.
US-based biopharmaceutical company AbbVie has signed a worldwide research licensing agreement with Canadian immuno-oncology company Turnstone Biologics for three of the latter’s oncolytic viral immunotherapies.
The three therapies are under development and based on the Maraba virus.
